IntelGenx Technologies (IGXT) has released an update.
IntelGenx Technologies Corp. successfully held its annual meeting virtually, with shareholders approving all proposed resolutions, including the election of eight directors, ratification of independent auditors, executive compensation, and a resolution on unallocated PRSUs. Over 62% of shareholders participated, indicating a strong interest and engagement with the company’s governance. IntelGenx, a prominent drug delivery company, continues to innovate in pharmaceutical films and offers a range of services to its partners.
For further insights into IGXT stock, check out TipRanks’ Stock Analysis page.
